Name | Number of supported studies | Average coverage | |
---|---|---|---|
mast cell | 20 studies | 33% ± 13% | |
ciliated cell | 4 studies | 26% ± 8% | |
astrocyte | 4 studies | 31% ± 12% | |
macrophage | 4 studies | 21% ± 3% | |
oligodendrocyte | 4 studies | 28% ± 7% | |
myeloid cell | 3 studies | 18% ± 1% | |
epithelial cell | 3 studies | 25% ± 8% | |
granulocyte | 3 studies | 34% ± 13% | |
GABAergic neuron | 3 studies | 36% ± 4% | |
glutamatergic neuron | 3 studies | 41% ± 1% | |
oligodendrocyte precursor cell | 3 studies | 25% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 34% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2338.71 | 653 / 653 | 99% | 19.64 | 600 / 605 |
breast | 100% | 2094.54 | 459 / 459 | 99% | 22.44 | 1105 / 1118 |
ovary | 100% | 2541.50 | 180 / 180 | 98% | 12.45 | 422 / 430 |
pancreas | 99% | 1202.43 | 324 / 328 | 98% | 24.33 | 175 / 178 |
adrenal gland | 100% | 2809.32 | 258 / 258 | 97% | 25.96 | 223 / 230 |
brain | 100% | 2454.04 | 2642 / 2642 | 97% | 26.07 | 682 / 705 |
lung | 100% | 3372.73 | 578 / 578 | 96% | 19.45 | 1114 / 1155 |
kidney | 100% | 1565.35 | 89 / 89 | 96% | 22.65 | 866 / 901 |
prostate | 100% | 1682.47 | 244 / 245 | 96% | 22.28 | 484 / 502 |
esophagus | 99% | 1220.06 | 1427 / 1445 | 94% | 25.93 | 172 / 183 |
stomach | 100% | 1551.72 | 359 / 359 | 92% | 23.07 | 262 / 286 |
skin | 100% | 1579.30 | 1808 / 1809 | 91% | 17.15 | 430 / 472 |
uterus | 100% | 1731.39 | 170 / 170 | 91% | 11.26 | 416 / 459 |
bladder | 100% | 1702.43 | 21 / 21 | 89% | 13.21 | 448 / 504 |
intestine | 100% | 1715.43 | 966 / 966 | 85% | 17.43 | 446 / 527 |
liver | 93% | 716.07 | 210 / 226 | 51% | 5.23 | 209 / 406 |
adipose | 100% | 2232.24 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 2219.68 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.16 | 1 / 1 |
blood vessel | 100% | 1454.99 | 1332 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 902.93 | 791 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1342.92 | 844 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 1421.16 | 890 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 9.09 | 39 / 45 |
lymph node | 0% | 0 | 0 / 0 | 86% | 10.57 | 25 / 29 |
eye | 0% | 0 | 0 / 0 | 85% | 9.80 | 68 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006683 | Biological process | galactosylceramide catabolic process |
GO_0042552 | Biological process | myelination |
GO_0046479 | Biological process | glycosphingolipid catabolic process |
GO_0043202 | Cellular component | lysosomal lumen |
GO_0005764 | Cellular component | lysosome |
GO_0004336 | Molecular function | galactosylceramidase activity |
Gene name | GALC |
Protein name | Galactosylceramidase Galactocerebrosidase (EC 3.2.1.46) Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactocerebroside beta-galactosidase) (Galactosylceramidase) (Galactosylceramide beta-galactosidase) Galactocerebrosidase (EC 3.2.1.46) (Galactosylceramidase) |
Synonyms | |
Description | FUNCTION: Hydrolyzes the galactose ester bonds of glycolipids such as galactosylceramide and galactosylsphingosine . Enzyme with very low activity responsible for the lysosomal catabolism of galactosylceramide, a major lipid in myelin, kidney and epithelial cells of small intestine and colon . . |
Accessions | H0YJG8 ENST00000393568.8 [P54803-3] ENST00000544807.6 [P54803-5] O95953 ENST00000261304.7 [P54803-1] G3V5E8 ENST00000555000.5 ENST00000554372.5 ENST00000555179.1 P54803 A0A087WX10 ENST00000622264.4 H0YJV6 G3V4M2 ENST00000393569.6 [P54803-4] G3V255 ENST00000556879.5 ENST00000557316.5 |